Cargando…
Application of Procalcitonin for the Rapid Diagnosis of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
Background: The incidence of Clostridioides difficile infection (CDI) has increased in recent years in patients with inflammatory bowel disease (IBD). C. difficile is a toxin-producing bacterium, and CDI results in the worsening of underlying IBD, increasing the risk of IBD treatment failure, surger...
Autores principales: | Xie, Shuhua, Chen, Peisong, Wang, Dong, Jiang, Xiaobing, Wu, Zhongwen, Liao, Kang, Liu, Min, Zhang, Shihong, Chen, Yili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776920/ https://www.ncbi.nlm.nih.gov/pubmed/36553115 http://dx.doi.org/10.3390/diagnostics12123108 |
Ejemplares similares
-
Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
por: Abdehagh, Mohammad, et al.
Publicado: (2021) -
The interplay of Clostridioides difficile
infection and inflammatory bowel disease
por: Sehgal, Kanika, et al.
Publicado: (2021) -
Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
por: Del Vecchio, Livio Enrico, et al.
Publicado: (2022) -
Management of Clostridioides difficile infection in patients with inflammatory bowel disease
por: Khanna, Sahil
Publicado: (2021) -
The Current Knowledge on Clostridioides
difficile Infection in Patients with Inflammatory Bowel Diseases
por: Boeriu, Alina, et al.
Publicado: (2022)